MedLumics pulls in Series B funds


Madrid-based MedLumics, a cardiac device company focused on optically guided minimally invasive instruments, has secured 34.4 million euros in Series B financing. Edmond de Rothschild Investment Partners led the round with participation from other investors that included Seroba Life Sciences, Innogest Capital, Ysios Capital Partners and Caixa Capital Risc. In addition to the funding, EdRIP’s Olivier Litzka, Innogest’s Claudio Rumazza and Seroba’s James Green have been named to MedLumics’ board of directors.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.